Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Stock data | 2023 | Change |
---|---|---|
Price | $1.87 | N/A |
Market Cap | $47.11M | N/A |
Shares Outstanding | 25.18M | 0.00% |
Employees | 296.00 | N/A |
Shareholder Equity | 739.53M | -44.94% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.15 | N/A |
P/S Ratio | 6.32 | N/A |
P/B Ratio | 0.06 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0050 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $7.46M | N/A |
Earnings | -$3.71M | N/A |
EPS | -12.33 | N/A |
Earnings Yield | -6.59 | N/A |
Gross Margin | 0.0202 | N/A |
Operating Margin | -0.537 | N/A |
Net income margin | -0.497 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $13.08M | N/A |
Total Debt | $777.34K | N/A |
Cash on Hand | $164.51K | N/A |
Debt to Equity | 0.0058 | 5.11% |
Cash to Debt | 0.2116 | 124.09% |
Current Ratio | 0.8360 | -33.21% |